JNJ-101556143 for prostatic neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 16 Sep 2026: Trial started, NCT07832292
  2. 21 Sep 2026: Trial registered, NCT07832292

The trials

NCT07832292: A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

State
Under way
Phase
Phase 2
People
100 planned
Started
16 Sep 2026
Primary completion
17 May 2029
Arms
JNJ-101556143
Results
None posted
  1. 16 Sep 2026: Trial started
  2. 21 Sep 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.